Printable version (PDF) 

OFF-LABEL USE

– Medical devices, whistleblower alleges unapproved use (S.D.W.Va.), 130
– “Reprint practices,” FDA issues guidance, 42

OFFICE OF HUMAN SUBJECT PROTECTION (OHRP)

– Economic recession and White House could change goals of OHRP, 172

OKLAHOMA

– Criminal penalties for stem cell research, veto stands, 331
– Reporting rule for stem cell research, In Brief, 161; adopted, 496; system created, In Brief, 621

OREGON

– Clinical trial insurance mandate, In Brief, 464

ORGAN TRANSPLANTS

– Bone failure and illegally obtained human tissue, too late to amend pleadings (D.N.J.), 233; production of documents ordered (D.N.J.), 318

ORPHAN DRUGS

– Clinical trials, FDA grants to fund, 17

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.